Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 607Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Adverse drug reactions to antiretroviral therapy: Results from spontaneous reporting system in Nigeria

Agu Kenneth A, Oparah Azuka C

Year : 2013| Volume: 4| Issue : 2 | Page no: 117-124

   This article has been cited by
1 Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon
Emmanuel Armand Kouotou,Jobert Richie Nansseu,Vanessa Nancy Ngono,Sandra A. Tatah,Anne Cecile Zoung-Kanyi Bissek,Elie Claude Ndjitoyap Ndam
Dermatology Research and Practice. 2017; 2017: 1
[Pubmed]  [Google Scholar] [DOI]
2 Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia
Marita Mann,Assegid Mengistu,Johannes Gaeseb,Evans Sagwa,Greatjoy Mazibuko,Jared M. Baeten,Joseph B. Babigumira,Louis P. Garrison,Andy Stergachis
Pharmacoepidemiology and Drug Safety. 2016;
[Pubmed]  [Google Scholar] [DOI]
3 Patterns of adverse drug reaction signals in NAFDAC Pharmacovigilance activities from September to November, 2014
Olufunsho Awodele,Ali Ibrahim,Paul Orhii
International Journal of Risk & Safety in Medicine. 2016; 28(1): 13
[Pubmed]  [Google Scholar] [DOI]
4 Pharmacovigilance in Nigeria: An Overview
Abimbola Olowofela,Annie Fourrier-Réglat,Ambrose O. Isah
Pharmaceutical Medicine. 2016;
[Pubmed]  [Google Scholar] [DOI]
5 Influence of Adverse Drug Reactions on Treatment Success: Prospective Cohort Analysis of HIV-Infected Individuals Initiating First-Line Antiretroviral Therapy in India
Anita Shet,Jimmy Antony,Karthika Arumugam,Sunil Kumar Dodderi,Rashmi Rodrigues,Ayesha DeCosta,Wenzhe Ho
PLoS ONE. 2014; 9(3): e91028
[Pubmed]  [Google Scholar] [DOI]


Read this article